Member Info for vizhy

It isn't clear but i read it the other way. He had 29m ish shares...now has 27.7m . I don't think the RNS is saying he has an additional "interest" in another 27m shares.

given how long this has taken is 15 years going to be enough!!!!

Blimin well hope so....get a move on
https://www.bloomberg.com/news/videos/2019-11-22/georgia-is-open-to-investors-says-vice-prime-minister-video

Great bit of business...but surely this should be 20/30% up on this news and cash in the coffers.

£150k i think

Whatever it is P&D or a real leak....we have bloody miles of SP to eat up before i am anywhere near a profit.!!!!

me too. even topped up at 20p!!!!!

echo your thoughts. average of 10p so been a while since i have been in profit but things shaping up nicely

Hoping good news from Te10. The brakes are on for TE11 because JP wants it too IMO. Difficult trading and the JP trading plan has got to off load a few before next month...wonder what that does to the SP over the next few weeks.

i am sure JP said at one of the cc or fsc that if things slowdown then it is on purpose and at his doing.

Sp was over a penny when this was just a possible outcome...now we are here when the news has been great and possible more to come/

lets hope this momentum keeps going.

doesn't say Potential awards at the top of the sheet.

to go for me until i get my stake back...roll on a 100% day please..

Mad how a buy like that doesn't move the price at all!! Too quiet. even the 10/15% over the past week or so was understated consider what we all hope to come in the next few months.

to show some confidence, rather than PI's find out through other means http://www.commodities-now.com/news/technology/20288-clean-energy-sourcing-selects-brady-to-manage-its-etrm-operations.html

think if news is soon then the sp would be getting closer to the poss 10/11p?

that was meant to say wish....i got out some years ago after doubling my £1k to £2k thinking i had got a good deal!!!!

I will i kept the £1k i had in this from the single figure pence days!!!

AGI Therapeutics (AGI) - Trading below net cash Drug developer AGI Therapeutics is currently valued at £2.6 million, well below its cash pile of $10 million (as at 31st December 2010). The firm concentrates its efforts in the area of specialty indications with unmet medical needs, with particular focus on treatments for conditions which qualify for Orphan Drug status (i.e. those drugs that are applicable for significant competitive advantages such as exclusivity periods, mainly due to the critical nature of the disease). The firm recently identified a promising new lead product candidate, AGI-350, (described as "a novel presentation of an existing marketed drug which AGI will develop to treat a significant unmet medical need in the critical care setting") for which a programme of pre-clinical testing has commenced. "AGI-350 is specifically formulated to allow effective and efficient delivery of the drug directly to the lung to treat a life-threatening, lung-related, condition. There are currently no formulations of the drug available for inhaled delivery, and AGI believes that AGI-350 will represent the first such approved use of the drug to treat the target critical care population." There are currently major changes underway in the pharmaceutical industry, notably the reduction in large pharma R&D budgets, that will see small biotech come under increasing scrutiny, both from the majors and the market in general. Tucking away a few of these might be a very rewarding punt over the next couple of years or so. The cash burn is around $3 million a year so plenty of space for interest to build here.